The 2.4-A crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium

E Sauvage1, F Kerff, E Fonzé

  • 1Centre d'Ingénierie des Protéines, Université de Liege, Institut de Physique, Belgium. eric.sauvage@ulg.ac.be

Insights

The crystal structure of Enterococcus faecium PBP5fm reveals unique active site features, including a rigid loop and a sterically hindering residue, explaining its low affinity for beta-lactam antibiotics and natural resistance.

Area of Science:

  • Structural Biology
  • Microbiology
  • Biochemistry

Background:

  • Penicillin-binding proteins (PBPs) are crucial for bacterial cell wall synthesis and are primary targets for beta-lactam antibiotics.
  • Enterococci exhibit natural resistance to beta-lactams due to specific PBPs with low antibiotic affinity, such as PBP5fm in Enterococcus faecium.

Purpose of the Study:

  • To elucidate the structural basis of beta-lactam resistance in Enterococcus faecium by determining the crystal structure of PBP5fm.
  • To identify key structural features within the PBP5fm active site that contribute to its low affinity for beta-lactam antibiotics.

Main Methods:

  • X-ray crystallography was employed to determine the structure of the acyl-enzyme complex of PBP5fm with benzylpenicillin.
  • High-resolution (2.4 A) structural analysis was performed to examine the active site topology and key residues.

Main Results:

  • The crystal structure revealed a unique loop (residues 451-465) at the active site's edge, conferring rigidity via an Arg464-Asp481 salt bridge.
  • The Val465 residue within this loop points into the active site, reducing accessibility and likely accounting for PBP5fm's low affinity for beta-lactams.
  • This structural motif is conserved in other low-affinity PBPs, such as PBP2a and PBP3.

Conclusions:

  • The specific loop topology and the presence of Val465 are critical determinants of PBP5fm's low affinity for beta-lactams, explaining Enterococcus's natural resistance.
  • Understanding these structural features provides insights into antibiotic resistance mechanisms and potential targets for drug development.

Related Concept Videos

Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...